False-Positive Human Immunodeficiency Virus Screening Results in Pregnancy During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Madison Miller, Rachel Cevigney, Mariam Ayyash, Majid Shaman, Monica Kole
Author Information
  1. Madison Miller: Department of Women's Health Services and the Division of Maternal-Fetal Medicine, Department of Women's Health Services, Henry Ford Health, and Wayne State University School of Medicine, Detroit, Michigan.

Abstract

False-positive human immunodeficiency virus (HIV) test results are rare but have been documented in the setting of certain underlying conditions such as Epstein-Barr virus, metastatic cancer, and certain autoimmune conditions. A retrospective cohort study in a large hospital system was conducted to compare the occurrence of false-positive HIV fourth-generation test results before and after the coronavirus disease 2019 (COVID-19) pandemic in a population of pregnant patients (N=44,187; 22,073 pre-COVID and 22,114 during COVID). The COVID cohort had a significantly higher frequency of false-positive HIV test results compared with the pre-COVID cohort (0.381 vs 0.676, P =.002). Within the COVID cohort, 25% of patients had a positive polymerase chain reaction test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preceding their false-positive HIV test results. When this subgroup was excluded, the difference in frequency of false-positive HIV test results between the cohorts was no longer significant (0.381 vs 0.507, P =.348). Our findings suggest that SARS-CoV-2 seropositivity was associated with an increased frequency of false-positive HIV test results in the pregnant population.

References

  1. Centers for Disease Control and Prevention. HIV surveillance report, 2016; vol. 28. Accessed March 2023, https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf
  2. Prenatal and perinatal human immunodeficiency virus testing. ACOG Committee Opinion No. 752. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;132:e138–42. doi: 10.1097/AOG.0000000000002825 [DOI: 10.1097/AOG.0000000000002825]
  3. Labor and delivery management of women with human immunodeficiency virus infection. ACOG Committee Opinion No. 751. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;132:e131–7. doi: 10.1097/AOG.0000000000002820 [DOI: 10.1097/AOG.0000000000002820]
  4. Salih RQ, Salih GA, Abdulla BA, Ahmed AD, Mohammed HR, Kakamad FH, et al. False-positive HIV in a patient with SARS-CoV-2 infection; a case report. Ann Med Surg 2021;71:103027. doi: 10.1016/j.amsu.2021.103027 [DOI: 10.1016/j.amsu.2021.103027]
  5. Tan SS, Chew KL, Saw S, Jureen R, Sethi S. Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results. J Clin Pathol 2021;74:614. doi: 10.1136/jclinpath-2020-206942 [DOI: 10.1136/jclinpath-2020-206942]

MeSH Term

Pregnancy
Female
Humans
COVID-19
SARS-CoV-2
Retrospective Studies
Pandemics
Epstein-Barr Virus Infections
COVID-19 Testing
Clinical Laboratory Techniques
Herpesvirus 4, Human
HIV Infections
HIV

Word Cloud

Created with Highcharts 10.0.0testHIVresultsfalse-positivecohort0COVIDfrequencyviruscertainconditionscoronavirus2019COVID-19populationpregnantpatients22pre-COVID381vsP=SARS-CoV-2False-positivehumanimmunodeficiencyraredocumentedsettingunderlyingEpstein-Barrmetastaticcancerautoimmuneretrospectivestudylargehospitalsystemconductedcompareoccurrencefourth-generationdiseasepandemicN=44187073114significantlyhighercompared676002Within25%positivepolymerasechainreactionresultsevereacuterespiratorysyndrome2precedingsubgroupexcludeddifferencecohortslongersignificant507348findingssuggestseropositivityassociatedincreasedFalse-PositiveHumanImmunodeficiencyVirusScreeningResultsPregnancyCoronavirusDiseasePandemic

Similar Articles

Cited By

No available data.